2024
DOI: 10.1016/j.jointm.2023.07.007
|View full text |Cite
|
Sign up to set email alerts
|

Severe dengue in the intensive care unit

Alexandre Mestre Tejo,
Debora Toshie Hamasaki,
Letícia Mattos Menezes
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(9 citation statements)
references
References 210 publications
0
0
0
Order By: Relevance
“…6 Severe Dengue is defined by one or more of the findings: 1) shock or respiratory distress, 2) bleeding, and 3) severe organ damage. 2 , 3 , 5 , 6 Patients with secondary infections are at risk of severity. Several co-existing conditions increase the risk of Severe Dengue: pregnancy, diabetes, hypertension, extremes of age (< 1 year and > 60 years), hemolytic anemia, chronic renal or hepatic failure, asthma, chronic obstructive pulmonary disease, and use of anticoagulants.…”
Section: Clinical Manifestationsmentioning
confidence: 99%
See 3 more Smart Citations
“…6 Severe Dengue is defined by one or more of the findings: 1) shock or respiratory distress, 2) bleeding, and 3) severe organ damage. 2 , 3 , 5 , 6 Patients with secondary infections are at risk of severity. Several co-existing conditions increase the risk of Severe Dengue: pregnancy, diabetes, hypertension, extremes of age (< 1 year and > 60 years), hemolytic anemia, chronic renal or hepatic failure, asthma, chronic obstructive pulmonary disease, and use of anticoagulants.…”
Section: Clinical Manifestationsmentioning
confidence: 99%
“…Vigilance of glycemic levels and discontinuation of oral hypoglycemic agents are warranted in diabetic patients. 5 Statins should be interrupted during Dengue infection due to their potential to increase transaminases and creatine kinase levels. 5 …”
Section: Preoperative Evaluationmentioning
confidence: 99%
See 2 more Smart Citations
“…The DENV has caused an estimated number of about 390 million infections globally and 500,000 cases of DHF/DSS annually, with 2.5 billion people at risk (4) .Over the years, the incidence and geographic distribution of DF has surged in many countries, particularly in those with tropical and sub-tropical climates. DENV has continuously increased in prevalence since the 1950's, making it the most common arthropod-borne viral disease worldwide currently, with the spread and circulation of multiple serotypes (5).…”
Section: Introductionmentioning
confidence: 99%